Multiple Sclerosis Clinical Trial

A Therapeutic Experience Program (TEP) Study for Improvement of Gait in People With Multiple Sclerosis (MS)

Summary

PoNS therapy is a rehabilitation program that uses the PoNS device in conjunction with individualized physical exercise. This is an outcome research open label observational interventional multi-center study investigating the relationship between subject's adherence to PoNS therapy and therapeutic outcomes.

View Full Description

Full Description

Study participants will undergo fourteen weeks of on-label PoNS therapy and, specifically, two weeks in-clinic PoNS therapy directly supervised by a physical therapist who has been trained on PoNS therapy by Helius Medical and certified as a clinic PoNS trainer (Phase 1) followed by 12 weeks of at-home unsupervised PoNS therapy Once weekly in-clinic PoNS therapy session (Phase 2). Subjects will be then asked to return to the clinic six month after the end of the study Phase 2 to assess maintenance of PoNS therapy effects.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Men and women ≥ 22 years of age with a diagnosis of MS.
EDSS scores < 6.5 at screening; a demonstrated gait deficit.
Can walk at least 10 meters with or without the use of walking aids.
Participants must be stable without relapse for at least 60 days and agree to PoNS therapy regimen.

Exclusion Criteria:

Other neurological, visual, or orthopedic problems that significantly interfere with balance or gait.
Dementia.
Subjects who are currently attending physical rehabilitation and are unwilling to switch to PoNS-specific physical therapy regimen.
Subjects who are already functional community ambulators (gait speed>120cm/s43).
Subjects will also be excluded as per the Helius Medical PoNS device indication for usage ("electrical stimulation should not be used: if there is an active or suspected malignant tumor; in areas of recent bleeding or open wounds; in areas that lack normal sensation; in women who are pregnant, or in people with sensitivity to nickel, gold or copper").

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

50

Study ID:

NCT05437276

Recruitment Status:

Recruiting

Sponsor:

Helius Medical Inc

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There are 5 Locations for this study

See Locations Near You

Shepherd Center
Atlanta Georgia, 30309, United States More Info
Casey Kandilakis
Contact
[email protected]
Deborah Backus, PT,Ph.D, FACRM
Principal Investigator
MGH Institute of Health Professions
Boston Massachusetts, 02129, United States More Info
Prudence Plummer
Contact
[email protected]
Prudence Plummer, PhD, PT, MSCS
Principal Investigator
Neurology Center of New England, P.C.
Foxboro Massachusetts, 02035, United States More Info
Rachel O'Donnell
Contact
[email protected]
Salvatore Napoli, MD
Principal Investigator
NYU Langone Health, NYU Grossman School of Medicine
New York New York, 10016, United States More Info
Luis Fernandez
Contact
[email protected]
Leigh E Charvet, PhD
Principal Investigator
Oregon Health and Science university (OHSU)
Portland Oregon, 97239, United States More Info
Carin Waslo
Contact
[email protected]
Vijayshree Yadav, MD, MCR
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Multiple Sclerosis

Estimated Enrollment:

50

Study ID:

NCT05437276

Recruitment Status:

Recruiting

Sponsor:


Helius Medical Inc

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.